Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Tong Cheng capsule for postoperative symptom improvement in orthopedic ERAS care
ChiCTR2300073992Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Tong Cheng capsule in Thoracolumbar vertebral compression fracture (TLVCF) and knee osteoarthritis (OA) (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: Time to postoperative pain VAS score decrease to 3 points and Time to first postoperative defecation. Started Jul 2023; status: recruiting.
02
Drugs
Tong Cheng capsule
03
Conditions
Thoracolumbar vertebral compression fracture (TLVCF)knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300073992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073992.